{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:34:54Z","timestamp":1789929294738,"version":"4.0.1"},"reference-count":48,"publisher":"Informa UK Limited","issue":"8","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.3111\/13696998.2014.917089","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T09:23:22Z","timestamp":1398245002000},"page":"567-576","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":23,"title":["Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States"],"prefix":"10.3111","volume":"17","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[{"name":"Department of Psychiatry & Behavioral Sciences, New York Medical College","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhesh A.","family":"Kamat","sequence":"additional","affiliation":[{"name":"Otsuka America Pharmaceutical, Inc.","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Sapin","sequence":"additional","affiliation":[{"name":"H. Lundbeck A\/S","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.","family":"Baker","sequence":"additional","affiliation":[{"name":"Otsuka Pharmaceutical Development and Commercialization, Inc.","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Eramo","sequence":"additional","affiliation":[{"name":"Lundbeck","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Ortendahl","sequence":"additional","affiliation":[{"name":"Partnership for Health Analytic Research, LLC","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Gutierrez","sequence":"additional","affiliation":[{"name":"Otsuka America Pharmaceutical, Inc.","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Hansen","sequence":"additional","affiliation":[{"name":"H. Lundbeck A\/S","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya G. K.","family":"Bentley","sequence":"additional","affiliation":[{"name":"Partnership for Health Analytic Research, LLC","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5,12]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0906"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-10-2"},{"key":"e_1_3_3_4_1","unstructured":"National Institute of Mental Health. Numbers count: mental disorders in America. 2013. www.nimh.nih.gov\/health\/publications\/the-numbers-count-mental-disorders-in-america\/index.shtml#Schizophrenia. Accessed December 19 2013"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.3.241"},{"issue":"16","key":"e_1_3_3_6_1","first-page":"14","article-title":"Relapse and rehospitalization: comparing oral and depot antipsychotics","volume":"64","author":"Schooler NR","year":"2003","unstructured":"Schooler NR. Relapse and rehospitalization: comparing oral and depot antipsychotics. J Clin Psychiatry 2003;64(16 Suppl):14\u201317","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201100084"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2012.739708"},{"key":"e_1_3_3_9_1","unstructured":"Lehman AF Lieberman JA Dixon LB et al. Practice guideline for the treatment of patients with schizophrenia second edition. American Psychiatric Association http:\/\/psychiatryonline.org\/content.aspx?bookID=28&sectionID=1665359. Accessed December 20 2013"},{"issue":"2","key":"e_1_3_3_10_1","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman AF","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, et al; American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1\u201356","journal-title":"Am J Psychiatry."},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a007071"},{"issue":"11","key":"e_1_3_3_12_1","first-page":"1","article-title":"Expert consensus guideline series: treatment of schizophrenia 1999","volume":"60","author":"McEvoy JP","year":"1999","unstructured":"McEvoy JP, Scheifler PL, Frances A. Expert consensus guideline series: treatment of schizophrenia 1999. J Clin Psychiatry 1999;60(11 Suppl):1\u201380","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_13_1","unstructured":"International Psychopharmacology Algorithm Project. www.ipap.org. Accessed December 19 2013"},{"key":"e_1_3_3_14_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3371\/CSRP.5.1.6","article-title":"Schizophrenia treatment guidelines in the United States","volume":"5","author":"Moore TA","year":"2011","unstructured":"Moore TA. Schizophrenia treatment guidelines in the United States. Clin Schizophr Relat Psychoses 2011;5:40\u20139","journal-title":"Clin Schizophr Relat Psychoses"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.195.52.s63"},{"key":"e_1_3_3_16_1","doi-asserted-by":"crossref","unstructured":"Kishimoto T Nitta M Borenstein M et al. Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies. J Clin Psychiatry 2013;74:957\u201365","DOI":"10.4088\/JCP.13r08440"},{"key":"e_1_3_3_17_1","doi-asserted-by":"crossref","unstructured":"Rossi G Frediani S Rossi R et al. Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations. BMC Psychiatry 2012;12:122","DOI":"10.1186\/1471-244X-12-122"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.2013.811984"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S16061"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbm033"},{"key":"e_1_3_3_21_1","unstructured":"Otsuka Pharmaceutical Company Inc. Aripiprazole prescribing information. 2013. Available at: http:\/\/www.otsuka-us.com\/Documents\/Abilify.PI.pdf. [Last accessed April 2014]"},{"key":"e_1_3_3_22_1","unstructured":"Janssen Pharmaceuticals Inc. Paliperidone palmitate injectable prescribing information. 2012. Available at: http:\/\/www.invegasustenna.com\/pdf\/invegasustenna-prescribing-info.pdf [Last accessed April 2014]"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-013-0016-2"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198529446.001.0001"},{"key":"e_1_3_3_25_1","unstructured":"Janssen Pharmaceuticals Inc. Risperidone long-acting injection prescribing information. 2012. Available at: http:\/\/www.janssencns.com\/risperdal\/risperdal-prescribing-information. [Last accessed April 2014]"},{"key":"e_1_3_3_26_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4088\/JCP.11m07530","article-title":"Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"75","author":"Kane J","year":"2012","unstructured":"Kane J, Sanchez R, Perry PP, et al. Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2012;75:617\u201324","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2009.10.026"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs150"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830130055011"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2003.10.010"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.554533"},{"key":"e_1_3_3_32_1","unstructured":"APP Pharmaceuticals LLC. Fluphenazine decanoate injection prescribing information. 2010. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/071413s019lbl.pdf [Last accessed April 2014]"},{"key":"e_1_3_3_33_1","unstructured":"Ortho-McNeil-Janssen Pharmaceuticals. Haloperidol decanoate injection prescribing information. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/018701s054lbl.pdf [Last accessed April 2014]"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-214"},{"key":"e_1_3_3_35_1","unstructured":"Medi-Span Price Rx.\u00ae https:\/\/pricerx.medispan.com\/ProductName.aspx. Accessed December 19 2013"},{"key":"e_1_3_3_36_1","unstructured":"US Department of Labor. Bureau of Labor Statistics. Archived consumer price index detailed report information. www.bls.gov\/cpi\/cpi_dr.htm. Accessed December 19 2013"},{"key":"e_1_3_3_37_1","unstructured":"US Department of Health & Human Services. Agency for Healthcare Research and Quality. HCUPnet. http:\/\/hcupnet.ahrq.gov. Accessed December 19 2013"},{"key":"e_1_3_3_38_1","unstructured":"US Department of Labor. Consumer Price Inflator. www.bls.gov\/cpi#data. Accessed March 28 2014"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200523001-00007"},{"key":"e_1_3_3_40_1","unstructured":"US Department of Labor. Occupational employment statistics. www.bls.gov\/oes\/current\/oes_nat.htm#29-0000. Accessed March 2 2014"},{"key":"e_1_3_3_41_1","unstructured":"US Department of Health and Human Services. Agency of Healthcare Research home page. http:\/\/hcupnet.ahrq.gov\/HCUPnet.jsp?Id=D19601906527E991&Form=SelCROSSTAB&JS=Y&Action=%3E%3ENext%3E%3E&_Oneway=Yes. Accessed March 28 2014"},{"key":"e_1_3_3_42_1","doi-asserted-by":"crossref","first-page":"A61","DOI":"10.1016\/j.jval.2013.03.1580","article-title":"Initial assessment of real-world usage of extended-release injectable paliperidone palmitate among medicaid insured schizophrenia patients","volume":"16","author":"Kamat S","year":"2013","unstructured":"Kamat S, Gutierrez B, Eramo A, et al. Initial assessment of real-world usage of extended-release injectable paliperidone palmitate among medicaid insured schizophrenia patients. Value Health 2013;16:A61","journal-title":"Value Health"},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2009.0063"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.11.1835"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.27.3.w185"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2008.59.5.540"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2006.00083.x"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.8.886"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903061309"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3111\/13696998.2014.917089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:29:58Z","timestamp":1770892198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3111\/13696998.2014.917089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,12]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.3111\/13696998.2014.917089"],"URL":"https:\/\/doi.org\/10.3111\/13696998.2014.917089","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-04-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}